Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» CRISPR Therapeutics
CRISPR Therapeutics
Vertex/CRISPR's gene editing therapy cost effective at $1.9 million - pricing review group
Yahoo/Reuters
Thu, 04/13/23 - 10:01 am
Vertex Pharmaceutials
CRISPR Therapeutics
gene therapy
sickle cell disease
ICER
Gene Editing Therapeutics Could Hit the Market in 2023
BioSpace
Mon, 04/10/23 - 11:32 am
gene editing
CRISPR Therapeutics
Vertex Pharmaceuticals
Intellia Therapeutics
Editas Medicine
Beam Therapeutics
Vertex and CRISPR Therapeutics Complete Submission of Rolling Biologics License Applications (BLAs) to the US FDA for exa-cel for the Treatment of Sickle Cell Disease and Transfusion-Dependent Beta Thalassemia
Yahoo/Businesswire
Mon, 04/3/23 - 10:09 am
Vertex Pharmaceuticals
CRISPR Therapeutics
sickle cell disease
beta thalassemia
FDA
exa-cel
Vertex ponies up $100M for CRISPR's gene editing tech to develop new diabetes modality
Endpoints
Tue, 03/28/23 - 11:46 am
Vertex Pharmaceuticals
diabetes
CRISPR
gene editing
CRISPR Therapeutics
CRISPR/ViaCyte and Genprex Vie for First Diabetes Gene Therapy
BioSpace
Mon, 03/13/23 - 10:21 am
ViaCyte
CRISPR Therapeutics
Genprex
diabetes
gene therapy
Medicaid, with planned payment pilot, girds for influx of pricey gene therapies
BioPharma Dive
Tue, 02/21/23 - 04:37 pm
Medicaid
sickle cell disease
gene therapies
Bluebird Bio
Vertex Pharmaceuticals
CRISPR Therapeutics
EMA validates Vertex's CRISPR application, clearing barrier on road to landmark approval
Fierce Biotech
Thu, 01/26/23 - 10:53 am
Vertex Pharmaceuticals
CRISPR Therapeutics
EMA
CRISPR
sickle cell disease
exa-cel
Two Aurinia execs are out — and CRISPR’s operations chief isn't far behind
Endpoints
Sun, 10/30/22 - 04:05 pm
Aurinia Pharmaceuticals
CRISPR Therapeutics
The gloom deepens for biopharma stocks
EP Vantage
Mon, 10/10/22 - 06:54 pm
biopharma stocks
AbbVie
Alnylam
AstraZeneca
Biogen
CRISPR Therapeutics
Daiichi Sankyo
Eisai
Eli Lilly
GSK
Intellia Therapeutics
Regeneron
Roche
Sanofi
Sarepta Therapeutics
Vertex given green light to seek US approval of CRISPR-based therapy
BioPharma Dive
Wed, 09/28/22 - 12:01 am
Vertex Pharmaceuticals
CRISPR
CRISPR Therapeutics
FDA
exa-cel
beta thalassemia
sickle cell disease
CRISPR Tx Drug Targeting CD70 Offers Early Hope for Difficult T Cell Lymphomas
BioSpace
Mon, 06/13/22 - 10:48 am
CRISPR Therapeutics
clinical trials
CTX130
CAR-T
solid tumors
T-cell lymphoma
CRISPR Therapeutics’ CAR-T for Lymphoma Shows Early Promise
BioSpace
Thu, 05/12/22 - 10:42 pm
CRISPR Therapeutics
CTX130
clinical trials
lymphoma
EHA
Record-breaking 2021 revenue shows there's more to Swiss biotech sector than Roche, Novartis
Fierce Biotech
Wed, 05/4/22 - 10:30 am
biotech
Switzerland
Novartis
Roche
Sophia Genetics
CRISPR Therapeutics
Why CRISPR Therapeutics Stock Is Soaring Today
Motley Fool
Tue, 03/8/22 - 10:52 pm
CRISPR Therapeutics
A big year for sickle cell
EP Vantage
Tue, 03/1/22 - 10:12 am
sickle cell disease
Agios
mitapivat
CRISPR Therapeutics
CTX001
clinical trials
CRISPR, ViaCyte beat Vertex to the clinic with diabetes cell therapy that evades the immune system
Endpoints
Tue, 11/16/21 - 10:34 am
CRISPR Therapeutics
ViaCyte
Vertex Pharmaceuticals
type 1 diabetes
cell therapy
gene editing
CRISPR touts new results as fresh questions surround 'off-the-shelf' CAR-T
BioPharma Dive
Tue, 10/12/21 - 11:40 pm
cancer
cell therapy
CRISPR Therapeutics
CRISPR Therapeutics takes a swing at ALS gene editing in discovery deal with AAV upstart Capsida
Endpoints
Tue, 06/15/21 - 10:37 am
CRISPR Therapeutics
ALS
gene editing
Capsida
Vertex puts a blockbuster valuation on its CRISPR deal
EP Vantage
Tue, 04/20/21 - 11:05 am
Vertex Pharmaceuticals
CRISPR Therapeutics
CRISPR
gene editing
CTX001
M&A
3 Biotech Stocks That Could Explode Higher in 2021
Motley Fool
Mon, 12/21/20 - 10:58 am
biotech
biotech stocks
clinical trials
FDA
Argenx
Axsome Therapeutics
CRISPR Therapeutics
Pages
« first
‹ previous
1
2
3
4
5
next ›
last »